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1. Introduction 
Liposomes have gained increasing importance as a 
means for the targeting of drugs [ l-31. Accumulation 
of liposomes with protein immobilized on their sur- 
face-specific macromolecules in desired regions has 
been described in both in vivo and in vitro systems 
[4,5]. Simple and quantitative methods of affinity 
proteins binding with the liposome surface without 
affecting the protein specific properties and liposome 
integrity should be developed. Several methods of 
protein immobilization on liposomes are known 
(review [6]) amongst which chemical methods seem 
to be the most attractive. According to these methods, 
proteins are directly chemically coupled with activated 
liposomes [7,8] or are incorporated into the liposome 
membrane after preliminary chemical modification 
with hydrophobic residues [9-l 11. In the latter case, 
the nature of hydrophobic modifier becomes very 
important for it should be easily available and physio- 
logically acceptable. Thus, for example&(NOL-iodo- 
acetyl,NE-dansyllysyl)-phosphatidylethanolamine 
used in [9] was specifically synthesized, although its 
toxity is not known. We have shown that non-mem- 
brane hydrophilic protein-enzyme cu-chymotrypsin 
can be successfully incorporated in liposome mem- 
brane during liposome formation by the detergent- 
dialysis method after preliminary modification of 
protein amino-groups with oxidized phosphatidylino- 
sitol. A high degree of protein binding is achieved and 
the enzyme thus immobilized preserves its ability to 
interact with high-Mr protein inhibitor. 
Kharkov bacterial preparations plant. Saturated phos- 
phatidylcholines, phosphatidylinositol (sodium salt), 
sodium cholate, cu-chymotrypsin and its pancreatic 
protein inhibitor were Sigma products. Specific sub- 
strate, N-acetyl-L-tyrosine ethyl ester (ATEE), was 
supplied by Koch-Light and dialysis tubes were from 
Union Carbide. 
2.1. Oxidation of phosphatidylinositol 
Phosphatidylinositol(2 mg) was dissolved in 2 ml 
0.01 M acetate buffer (pH 5.6) and the solution sup- 
plemented with 1.5-, lo- or 20-fold molar excess of 
NaIO,,. The mixture was stirred for 10-I 5 h at 20°C 
or 4°C in the dark. Then a lo-fold molar excess (to 
perlodate) of ethyleneglycol was added and mixture 
was incubated in the dark for 3-4 h. Micelles of mod- 
ified phosphatidylinositol were separated by gel-filtra- 
tion on minicolumns with Sephadex G-50 in a centri- 
fuge [ 121. During this process phospholipid was trans- 
ferred in carbonate buffer (pH 9.2). 
2.2. Modification of a-chymotrypsin 
2. Materials and methods 
Egg yolk phosphatidylcholine was the product of 
The solution of oxidized phosphatidylinositol 
(1 ml) was added into 4 ml cu-chymotrypsin solution 
(final cont. 5 X lo-’ M) in 0.05 M carbonate buffer 
(pH 9.2) and the mixture was incubated overnight at 
4’C. Then, 5 mg sodium borohydride were added and 
mixture was incubated for additional 12- 15 h. Low- 
M, compounds were separated by gel-filtration on 
Sephadex G-50 in the centrifuge. Modified a-chymo- 
trypsin bound with micelles of oxidized phosphatidyl- 
inositol was separated from native protein by gel- 
filtration on Sephadex G-100. Additional purification 
of modified protein from non-bound phosphatidyl- 
inositol was performed on a Whatman phosphocellu- 
lose column equilibrated with lop2 M acetate buffer 
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(pH 4) containing 0.5% of Triton X-100 (ICN). 
Protein on the column was washed with Triton-con- 
taining buffer, then with Triton-free buffer and was 
then eluted with 50 mM phosphate (pH 8). When 
necessary, modified protein was dialyzed against 
5 mM NaJ-IP04 buffer (pH 8) containing 0.145 M 
NaCl before binding experiments. 
2.3. Preparation of liposomes and protein immobiliza- 
tion 
Liposome preparation by the cholate dialysis 
method with simultaneous protein immobilization 
was performed as in [lo]. The solution of modified 
a-chymotrypsin was mixed with the solution of phos- 
phatidylcholine and trace amounts of [3H]cholesterol 
in the 5 mM phosphate buffer (pH S), containing 
0.145 M NaCl and 2% of sodium cholate and the mix- 
ture was dialyzed against a 500-fold excess of the 
same buffer without cholate. 
Liposomes were separated from non-bound ar-chy- 
motrypsin by gel-filtration on a Sepharose CL4B 
column (1.5 X 30 cm) or in the centrifuge using 5 ml 
columns. Minicolumns were first centrifuged for 
10 min at 50 X g, then for 10 min at 500 X g. Of the 
sample 0.5 ml was applied on each minicolumn and 
centrifuged for 10 min at 50 X g, then for 10 min at 
500 X g. As a result, free protein was retained on the 
column and liposomes with immobilized enzyme 
were collected from the bottom of the tube. In some 
cases free protein was separated from liposome by 
flotation in dextran solution as in [ 131. Protein con- 
centration in each fraction was determined following 
its enzymatic activity and lipid concentration (fol- 
lowing 3H-radioactivity). Liquid Scintillation System 
Mark III 6880 (Searle) was used. Catalytic activity 
measurements, apparent Michaelis constant determi- 
nation and inhibition studies were performed as in [lo]. 
3. Results and discussion 
Periodate treatment activates phosphatidylinositol 
through carbohydrate unit oxidation with the forma- 
tion of reactive aldehyde groups which can form Schiff 
bases with protein amino-groups. Schiff bases, in 
turn, can be reduced to stable -C-N bonds by treat- 
ment with sodium borohydride. 
Upon solubilization of native or oxidized phos- 
phatidylinositol sodium salt in experimental condi- 
tions a transparent solution is formed, containing, 
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probably, small monolamellar liposomes (phospha- 
tidylinositol does not form micelles, but only mem- 
brane-like bilayer structures [ 141). The phospholipid 
structures formed are eluted in the void volume on 
Sephadex G-l 00 columns and modified with oxidized 
phosphatidylinositol a-chymotrypsin. c&hymotrypsin, 
which is associated with these structures, can thus be 
separated from native, non-modified enzyme (see 
fig.1). It was found that non-oxidized phosphatidyl- 
inositol practically does not bind protein (i.e., modi- 
fication does not occur) whereas oxidized phospha- 
tidylinositol easily binds protein. The more rigid the 
conditions used for oxidation the higher the amounts 
of protein that are associated with phospholipid 
structures (cf: curves l-3 in fig.1). 
In optimal conditions up to 50% of enzymic activ- 
ity was eluted in the void volume. From the known 
composition of the incubation mixture (0.2 mg 
phosphatidylinositol/ml and 5 X IO-’ M protein) it 
can be calculated that molar phospholipid-protein 
ratio in the aggregates formed is -10: 1. Such a high 
protein concentration makes doubtful the existence 
of membrane structures in experimental conditions; 
we are probably dealing with non-ordered aggregates 
consisting of native phospholipid, oxidized phospho- 
lipid and modified protein. 
Modified cw-chymotrypsin readily incorporates into 
liposome membranes during the process of liposome 
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Fig.1. Gel-filtration on Sephadex G-100 of different prepara- 
tions of a-chymotrypsin premcubated with phosphatidylino- 
sitol: (1) non-oxidized phosphatidylinositol; (2) phosphatidyl- 
inositol oxidized in mild conditions (4”C, 1 S-fold molar 
excess of periodate); (3) phosphatidylinositol oxidized in 
rigid conditions (2O”C, 15-fold molar excess of periodate). 
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Table 1 
The binding of native and modified or-chymotrypsin with liposomes 
Sample Protein 
(M) 
Lipid 
(mg/ml) 
Bound protein 
(mol/mol lipid) 
Pure, non-modified 
cu-chymotrypsin 2.5 x 10-s 2.5 1.3 x 1o-s 
Non-modified or-chymo- 
trypsin in the presence 
of non-oxidized phos- 
phatidylinositol 1.7 x 10-s 2.5 5.3 x 1o-5 
c&hymotrypsin, 
moditied with oxi- 
dized phosphatidyl- 
inositol 
(a) 5.3 x 10m6 2.5 1.8 x 1O-4 
(b) 1.06 x 1O-5 2.5 1.1 x 10-S 
(c) 1.06 x lo-’ 1.25 2.4 x 1O-3 
formation by the detergent-dialysis method. The 
degree of binding depends on protein and phospha- 
tidylinositol concentrations (see table 1) and in optimal 
conditions it can be as high as 2.4 X 1 OT3 mol enzyme/ 
mol lipid. It means that in the case, for example, of 
monolamellar liposomes with diam. -1000 A, con- 
taining lo5 lipid molecules [ 151,240 molecules of 
active enzyme are bound/single liposome, and simple 
calculations show that 20% of liposome surface is 
coated with the protein (assuming that the liposome 
membrane is impermeable for substrate and products 
of its decomposition, and we are dealing only with 
the protein located on the outer surface of liposome 
[lOI)* 
The method developed is specially designed for 
construction of drug targeting systems, and therefore 
the specific properties of the bound protein should be 
maximally preserved in the process of immobilization, 
or at least, the changes in these properties, which are 
the result of modification or immobilization, should 
be known. From this point of view an enzyme can 
serve as a very convenient model, because its ability 
to bind specific substrates and inhibitors or to catalyze 
chemical reactions can be easily characterized quanti- 
tatively . 
Modification and immobilization only slightly 
change catalytic activity of the native enzyme and its 
apparent Michaelis constant (Km) in the reaction of 
ATEE hydrolysis: after modification and immobiliza- 
tion, the enzyme preserves of -70% of the initial 
activity and Km-values for native and immobilized 
enzyme are 0.7 and 0.4 m.M, respectively. The changes 
in catalytic constant (Kcat) (which in the case of 
modified enzyme was determined by titration of 
enzyme active centers withp-nitrophenylacetate [ 161) 
are also within the limits of experimental error. 
The study of the ability of modified and immobi- 
lized cu-chymotrypsin to interact with high-ikfr pan- 
creatic inhibitor (M, N 6000) has shown that modifi- 
cation does not change this ability and even in the 
immobilized state >90% of active enzyme can still 
be inhibited (see fig.2). The observed high degree of 
preservation of enzyme-specific properties can be 
explained by low modification degree (unfortunately, 
it cannot be shown directly by, for example, titrating 
protein-free amino-groups, due to experimental diffi- 
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Fig.2. Inhibition of achymotrypsm with protein pancreatic 
inhibitor: (1) native enzyme; (2) enzyme modified with oxi- 
dized phosphatidylinositol; (3) enzyme immobilized on lipo- 
some surface after modification. 
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culties connected with the existence of the two-phase 
system) or by the fact that the phosphatidylinositol 
residue serves as a ‘spacer’ group separating the mole- 
cule of the immobilized enzyme from the liposome 
surface and thus eliminating steric hindrances [8]. 
4. Conclusions 
(1) Phosphatidylinositol can serve as an hydrophobic 
anchor for immobilization of hydrophilic proteins on 
liposome surface. Binding degree reaches 2.4 X 10s3 
mol protein/mol lipid. 
(2) About 90% of immobilized protein preserves 
specific affinity towards a high-MI ligand. 
(3) Since phosphatidylinositol is a natural non-toxic 
phospholipid the method developed may be useful in 
drug targeting experiments. 
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